Ostigard Plus 50 mg/325 mg Tablet
Prescription Required
Introduction of Ostigard Plus Tablet
Ostigard Plus 50 mg/325 mg Tablet is a medicine used in the treatment of arthralgia (joint pain). It helps reduce pain and inflammation in the joints. It also helps in building soft connective tissue that cushions the joints.
Ostigard Plus 50 mg/325 mg Tablet is a combination of two medicines: Ostigard Plus 50 mg/325 mg Tablet1 and Ostigard Plus 50 mg/325 mg Tablet2.
Ostigard Plus 50 mg/325 mg Tablet is a combination of two medicines: Ostigard Plus 50 mg/325 mg Tablet1 and Ostigard Plus 50 mg/325 mg Tablet2.
Uses of Ostigard Plus Tablet
Benefits of Ostigard Plus Tablet
In Arthralgia (joint pain)
Arthralgia is a condition with pain and stiffness in the joints that causes difficulty in movement. Ostigard Plus 50 mg/325 mg Tablet helps in reducing this pain and stiffness. It also reduces swelling in the joints. Altogether, it helps in easy movement. Ostigard Plus 50 mg/325 mg Tablet if taken at the start of symptoms of arthralgia might prevent further damage of the joints. This will help you do your daily activities more easily and thus improve your quality of life. Ostigard Plus 50 mg/325 mg Tablet should be taken at the same time each day to get maximum benefits. You should continue taking it until your doctor asks you to stop.
Side effects of Ostigard Plus Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Ostigard Plus
- No common side effects seen
How to use Ostigard Plus Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ostigard Plus 50 mg/325 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Ostigard Plus 50 mg/325 mg Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Ostigard Plus 50 mg/325 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Ostigard Plus 50 mg/325 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
CONSULT YOUR DOCTOR
It is not known whether Ostigard Plus 50 mg/325 mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
SAFE IF PRESCRIBED
Ostigard Plus 50 mg/325 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Ostigard Plus 50 mg/325 mg Tablet may not be needed in these patients. Please consult your doctor.
Liver
UNSAFE
Ostigard Plus 50 mg/325 mg Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
What if you forget to take Ostigard Plus Tablet?
If you miss a dose of Ostigard Plus 50 mg/325 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
Ostigard Plus Tablet
- You have been prescribed Ostigard Plus 50 mg/325 mg Tablet for the treatment of joint pain.
- It may increase your blood sugar level. If you are diabetic, monitor your levels regularly.
- Do light exercise or take physical therapy to strengthen muscles around the affected joint and manage your weight along with taking this medication.
Fact Box
Habit Forming
No
Therapeutic Class
PAIN ANALGESICS
Patient concerns
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Fidelix TS, Macedo CR, Maxwell LJ, et al. Diacerein for osteoarthritis. Cochrane Syst Rev. 2014;(2):CD005117. [Accessed 19 Apr. 2019] (online) Available from:
- ScienceDirect. Diacerein. [Accessed 19 Apr. 2019] (online) Available from:
- Drugs.com. Paracetamol. [Accessed 19 Apr. 2019] (online) Available from:
Marketer details
Name: Zydus Cadila
Address: Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
DISCONTINUED
We do not facilitate sale of this product at present